0.2485
price up icon2.05%   0.005
pre-market  Pre-mercato:  .25   0.0015   +0.60%
loading

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
7.04%
7.3779
7.9365 7.3125 6.3084 6.6541
Costs And Expenses
4.35%
12.00
12.55 9.4135 8.294 8.7053
Operating Income/Loss
4.35%
-12.00
-12.55 -9.4135 -8.294 -8.7053
Nonoperating Income/Loss
290.11%
-9.5802
5.0392 -4.3189 0.0728 0.124
Income/Loss From Continuing Operations Before Tax
3.19%
-12.00
-11.63 -9.4135 -8.2212 -8.5813
Income/Loss From Continuing Operations After Tax
189.74%
-21.58
-7.4487 -13.73 -8.2212 -8.5813
Net Income/Loss
189.74%
-21.58
-7.4487 -13.73 -8.2212 -8.5813
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,008%
29.35
0.9443 11.31 11.26 11.26
Diluted Average Shares
3,008%
29.35
0.9443 11.31 11.26 11.26
Basic Earnings Per Share
85.00%
-0.74
-0.40 -1.21 -0.73 -0.76
Diluted Earnings Per Share
85.00%
-0.74
-0.40 -1.21 -0.73 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):